The endothelin axis: emerging role in cancer.

Collectively, the endothelins and their receptors--referred to as the endothelin (ET) axis--have key physiological functions in normal tissue, acting as modulators of vasomotor tone, tissue differentiation, development, cell proliferation and hormone production. Based on new data, the ET axis also functions in the growth and progression of various tumours. Preliminary results from clinical trials, such as those with atrasentan--an ET(A)-receptor antagonist--in prostate cancer, are encouraging. The place of ET-receptor antagonists in cancer therapy for a range of malignancies merits further investigation.
AuthorsJoel Nelson, Anna Bagnato, Bruno Battistini, Perry Nisen
JournalNature reviews. Cancer (Nat Rev Cancer) Vol. 3 Issue 2 Pg. 110-6 (Feb 2003) ISSN: 1474-175X [Print] England
PMID12563310 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Endothelin Receptor Antagonists
  • Endothelins
  • Pyrrolidines
  • Receptor, Endothelin A
  • Receptors, Endothelin
  • atrasentan
  • Amino Acid Sequence
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Clinical Trials as Topic
  • Endothelin Receptor Antagonists
  • Endothelins (physiology)
  • Humans
  • Male
  • Neoplasms (physiopathology)
  • Prostatic Neoplasms (drug therapy, physiopathology)
  • Protein Conformation
  • Pyrrolidines
  • Receptor, Endothelin A
  • Receptors, Endothelin (chemistry, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: